CGEM · Cullinan Therapeutics, Inc. · Documents
$15.65
+0.02 (+0.10%)
At close · Oct 8
Return incl. dividend (before tax)
Market Cap
$965.19M
Shares
64.35M
Volume · Oct 8
450.22K
Avg daily vol (3M)
867.31K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-10-02 | 2026-10-01 | |
| 8-K | 2026-09-24 | — | |
| 8-K | 2026-09-14 | 2026-09-13 | |
| 8-K | 2026-08-13 | 2026-08-12 | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-16 | — | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-06-08 | 2026-06-06 | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-04-27 | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-11-21 | 2025-11-18 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-04-24 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-29 | 2025-01-28 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-09-17 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-27 | 2024-06-26 | |
| 8-K | 2024-06-03 | 2024-06-01 | |
| 8-K | 2024-05-23 | — | |
| DEF 14A | 2024-05-16 | 2024-06-26 | |
| 8-K | 2024-05-15 | 2024-05-09 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-04-29 | — | |
| 8-K | 2024-04-16 | 2024-04-15 | |
| 8-K | 2024-03-14 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K/A | 2024-01-08 | — | |
| 8-K | 2024-01-08 | — |
Showing 1–50 of 96 filings